IMS Health (IMS), Quintiles (Q) Announce Post-Merger Exec Appointments

August 29, 2016 6:48 AM EDT

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

IMS Health Holdings, Inc. (NYSE: IMS) and Quintiles Transnational Holdings Inc. (NYSE: Q) announced key senior management roles in the future Quintiles IMS corporate leadership team, subject to the completion of the merger.

Senior functional leaders reporting to Chairman and Chief Executive Officer Ari Bousbib will include Michael McDonnell, EVP and Chief Financial Officer; James Erlinger, EVP and General Counsel; and Trudy Stein, EVP and Chief Human Resources Officer.

Global business leaders reporting to Mr. Bousbib will include, for the clinical research business, Tom Pike, Vice Chairman and President, Research & Development Solutions; and for the commercial business, Kevin Knightly, President, Information and Technology Solutions; José Luis Fernández, President, Global Services; Jon Resnick, President, Real-World Insights; and Scott Evangelista, President, Contract Sales Organization.

“I am proud to be part of a leadership team with deep industry knowledge, a proven track record of success and a commitment to transforming healthcare for the better,” said Ari Bousbib. “That commitment extends across the 50,000 talented professionals who will soon become part of one global team. Together, we are making excellent progress on our integration planning and are confident that we will be ready for a strong start on day one of the merger.”

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Corporate News, Management Changes

Related Entities

Definitive Agreement

Add Your Comment